@cbpolis For those interested in the differences (same contraceptive API, but different delivery route and dose), check out @cbpolis and colleagues' pre-ECHO commentary discussing HIV risk for Sayana Press (DMPA-SC) and DMPA-IM: https://t.co/4wvqYkpD4i
Excellent point, @AmesMack. Sayana Press was not included in #ECHO trial, but pictured in @nytimes. This 2018 paper considered similarities & differences between DMPA-IM & Sayana Press: https://t.co/Dx0kJnQbXT. And this one explored DMPA &
RT @cbpolis: Following along to #DMPASC2018. Our commentary considers whether DMPA-SC is likely to impact women's risk of HIV acquisition:…
Good insights to look at! I’m attending a civil society forum on hormonal contraception and HIV in Nairobi about ECHO trial in Kenya. A randomised clinical trial on hormonal contraceptives and the risk of HIV acquisition. https://t.co/ZW2En7L3F1